UBS raised the firm’s price target on Marsh McLennan (MMC) to $261 from $259 and keeps a Buy rating on the shares. UBS likes the defensive nature of P&C insurance heading into 1Q25 results, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC: